chevron_leftBack
As of 24 April 2025, BRAIN Biotech AG has a market cap of $58.18M USD, ranking #23780 globally and #301 in Germany. It ranks #2533 in the Basic Materials sector, and #644 in the Specialty Chemicals industry.
Key Stats
Market Cap
$58.18MUSD
51.34M EUR
Enterprise Value
$37.99MUSD
33.52M EUR
Revenue (TTM)
$63.25MUSD
55.82M EUR
EBITDA (TTM)
-$7.15MUSD
-6.31M EUR
Net Income (TTM)
-$14.18MUSD
-12.52M EUR
EBITDA Margin
-11%
Profit Margin
-22%
Company Profile
Country (HQ)
Sector
Basic Materials
Industry
Specialty Chemicals
CEO
Adriaan Moelker
open_in_new
Employees
318
Founded
1993
Website
brain-biotech.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.4% | -2.5% | -7.2% | -29% | -14% | -19% |
Upcoming Earnings
Earnings Date
Wed, May 28
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
BNN
ISIN: DE0005203947
Shares Out.:
Shares Outstanding:
21.847M1
Shares Float:
10.11M2
|
2.34 EUR | |
|
0RFI
ISIN: DE0005203947
|
2.29 EUR | |
|
BNN
ISIN: DE0005203947
|
2.36 EUR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About BRAIN Biotech AG
BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates through three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes, biocatalysts, microorganisms, and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. The company was founded in 1993 and is headquartered in Zwingenberg, Germany.
